PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.95%
Positive revenue growth while 3391.T is negative. John Neff might see a notable competitive edge here.
9.53%
Positive gross profit growth while 3391.T is negative. John Neff would see a clear operational edge over the competitor.
43.67%
EBIT growth similar to 3391.T's 47.74%. Walter Schloss might infer both firms share similar operational efficiencies.
30.10%
Operating income growth 1.25-1.5x 3391.T's 25.52%. Bruce Berkowitz would see if strategic measures (e.g., cost cutting, product mix) are succeeding.
42.72%
Net income growth at 50-75% of 3391.T's 80.67%. Martin Whitman would question fundamental disadvantages in expenses or demand.
42.72%
EPS growth at 50-75% of 3391.T's 74.25%. Martin Whitman would suspect a lag in operational efficiency or a higher share count.
42.72%
Diluted EPS growth at 50-75% of 3391.T's 74.24%. Martin Whitman would question if share issuance or modest net income gains hamper progress.
-0.00%
Share reduction while 3391.T is at 0.09%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.06%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Both companies cut dividends. Martin Whitman would look for a common factor, such as cyclical downturn or liquidity constraints.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
22.78%
10Y CAGR of 22.78% while 3391.T is zero. Bruce Berkowitz would see if incremental growth can widen into a significant edge.
-7.65%
Negative 5Y CAGR while 3391.T stands at 77.84%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
35.01%
3Y revenue/share CAGR at 50-75% of 3391.T's 57.13%. Martin Whitman would question if the firm lags behind competitor innovations.
-100.00%
Negative 10Y OCF/share CAGR while 3391.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.39%
10Y net income/share CAGR of 70.39% while 3391.T is zero. Bruce Berkowitz would see if minor gains can compound into a bigger lead over time.
2.81%
Below 50% of 3391.T's 86.96%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
47.84%
3Y net income/share CAGR 75-90% of 3391.T's 60.31%. Bill Ackman might push for an operational plan to match or beat the competitor’s short-term growth.
No Data
No Data available this quarter, please select a different quarter.
28.23%
Below 50% of 3391.T's 87.65%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
68.77%
3Y equity/share CAGR above 1.5x 3391.T's 44.57%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
-100.00%
Cut dividends over 10 years while 3391.T stands at 0.00%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-99.16%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.48%
Inventory is declining while 3391.T stands at 1.65%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
1.44%
Positive asset growth while 3391.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
5.18%
BV/share growth above 1.5x 3391.T's 1.56%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-25.72%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
No Data
No Data available this quarter, please select a different quarter.
101.71%
We expand SG&A while 3391.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.